Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.030
0.00 (0.00%)
Nov 19, 2026, 4:00 PM EST - Market closed
Veraxa Biotech AG Market Cap
Veraxa Biotech AG has a market cap or net worth of $145.65 million as of November 19, 2026. It is the 22,151st most valuable company in the world and the 3,727th biggest in the United States. Its market cap has decreased by 56.18% in one year.
Market Cap
145.65M
Enterprise Value
145.05M
1-Year Change
-56.18%
Global Rank
Country Rank
#3,727 United States
Category
ChartMarket Cap Chart
Since September 30, 2024, Veraxa Biotech AG's market cap has decreased from $315.30M to $145.65M, a decrease of -53.81%. That is a compound annual growth rate of -30.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 145.65M | -56.84% |
| Dec 31, 2025 | 337.44M | 6.49% |
| Dec 30, 2024 | 316.88M | 0.50% |
| Sep 30, 2024 | 315.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 158.75M |
| Zentalis Pharmaceuticals | 157.23M |
| Sutro Biopharma | 154.73M |
| Humacyte | 150.09M |
| Abeona Therapeutics | 148.58M |
| Protara Therapeutics | 146.54M |
| Sionna Therapeutics | 141.13M |
| Atrium Therapeutics | 138.70M |